Bufalin alleviates inflammatory response and oxidative stress in experimental severe acute pancreatitis through activating Keap1-Nrf2/HO-1 and inhibiting NF-κB pathways
International Immunopharmacology · 2024-12 · 142 · 113113
DOI: 10.1016/j.intimp.2024.113113 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024-12. Verfasst von Xiaolong Niu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai University of Traditional Chinese Medicine, Shanghai, China; Shanghai Innovation Center of TCM Health Service, Shanghai University of Tradit…. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Kelch-Like ECH-Associated Protein 1, Pancreatitis, Oxidative Stress. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Science and Technology Commission of Shanghai Municipality.
Abstract (Originalsprache)
Severe acute pancreatitis (SAP) is a prevalent acute inflammatory disease that is clinically manifested by systemic inflammation dysregulation, resulting in a significantly elevated mortality rate. Bufalin has been verified to have potent pharmacological properties, including analgesic, anti-tumor and anti-inflammatory effects. However, it remains unclear whether bufalin inhibits SAP. Thus, we aim to explore the impact of bufalin in SAP rats and to evaluate the potential mechanisms of action. In addition to analyzing serum biochemistry and pancreatic tissue pathology, we elucidated its mechanisms of action through enzyme-linked immunosorbent assay (ELISA), immunohistochemical analysis, Western blot, and quantitative real-time PCR. The results demonstrated that bufalin dose-dependently reversed the elevation of serum Amylase (Amy) and Lipase (LPS) levels in SAP rats, alleviating pancreatic tissue pathological damage. Bufalin exhibited potent antioxidant effects by reducing malondialdehyde (MDA) levels, decreasing Superoxide dismutase (SOD) and glutathione(GSH) consumption, inhibiting the interaction of Keap1-Nrf2, and increasing HO-1 expression. Furthermore, bufalin inhibited TNF-α, IL-6, IL-1β, p-NF-κB-p65, p-IκBα, and NF-κB-p65 expression, while enhancing IκBα expression, ultimately confirming its anti-inflammatory effects on SAP. In summary, our findings suggest that bufalin exerts anti-inflammatory and antioxidant actions in NaT-SAP rats by inhibiting NF-κB and activating the Keap1-Nrf2/HO-1 pathway. This study represents the inaugural application of bufalin in NaT-induced SAP rats, indicating its potential as an effective therapeutic agent for SAP patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai University of Traditional Chinese Medicine, Shanghai, China; Shanghai Innovation Center of TCM Health Service, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Shanghai University of Traditional Chinese Medicine, Shanghai, China; Center for Drug Safety Evaluation and Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Shanghai University of Traditional Chinese Medicine, Shanghai, China; Shanghai Innovation Center of TCM Health Service, Shanghai University of Traditional Chinese Medicine, Shanghai, China; Center for Drug Safety Evalua…
Förderung
- Science and Technology Commission of Shanghai Municipality
Zitieren
APA
Niu, X., Sun, W., Tang, X., Chen, J., Zheng, H., Yang, G., & Yao, G. (2024). Bufalin alleviates inflammatory response and oxidative stress in experimental severe acute pancreatitis through activating Keap1-Nrf2/HO-1 and inhibiting NF-κB pathways. International Immunopharmacology, 142, 113113. https://doi.org/10.1016/j.intimp.2024.113113
Vancouver
Niu X, Sun W, Tang X, Chen J, Zheng H, Yang G, et al. Bufalin alleviates inflammatory response and oxidative stress in experimental severe acute pancreatitis through activating Keap1-Nrf2/HO-1 and inhibiting NF-κB pathways. International Immunopharmacology. 2024;142:113113. doi:10.1016/j.intimp.2024.113113
BibTeX
@article{Niu2024,
author = {Niu, Xiaolong and Sun, Wei and Tang, Xiaohang and Chen, Jialiang and Zheng, Huaqun and Yang, Guimei and Yao, Guangtao},
title = {Bufalin alleviates inflammatory response and oxidative stress in experimental severe acute pancreatitis through activating Keap1-Nrf2/HO-1 and inhibiting NF-κB pathways},
journal = {International Immunopharmacology},
year = {2024},
volume = {142},
pages = {113113},
doi = {10.1016/j.intimp.2024.113113}
}
EUVIMED